[go: up one dir, main page]

AR132185A1 - COMPUESTOS DE 1-H-PIRROLO[2,3-c]PIRIDINA - Google Patents

COMPUESTOS DE 1-H-PIRROLO[2,3-c]PIRIDINA

Info

Publication number
AR132185A1
AR132185A1 ARP240100690A ARP240100690A AR132185A1 AR 132185 A1 AR132185 A1 AR 132185A1 AR P240100690 A ARP240100690 A AR P240100690A AR P240100690 A ARP240100690 A AR P240100690A AR 132185 A1 AR132185 A1 AR 132185A1
Authority
AR
Argentina
Prior art keywords
compounds
salts
pyrrolo
pyridine compounds
menin
Prior art date
Application number
ARP240100690A
Other languages
English (en)
Inventor
Stephen Atkinson
Martin Packer
Bruin Gerjan De
Chimed Jansen
Saskia Verkaik
Robin Voets
Flavia Izzo
Olaf Kinzel
Original Assignee
Acerta Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acerta Pharma Bv filed Critical Acerta Pharma Bv
Publication of AR132185A1 publication Critical patent/AR132185A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos que tienen la estructura de fórmula (1), y sales farmacéuticamente aceptables de los mismos, en donde R¹, R², R³, R⁴ y A son como se definen en la especificación; composiciones farmacéuticas que comprenden estos compuestos y sales; uso de estos compuestos y sales para tratar o prevenir condiciones mediadas por menina; kits que comprenden estos compuestos y sales; y métodos para fabricar estos compuestos y sales.
ARP240100690A 2023-03-24 2024-03-21 COMPUESTOS DE 1-H-PIRROLO[2,3-c]PIRIDINA AR132185A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202363491978P 2023-03-24 2023-03-24

Publications (1)

Publication Number Publication Date
AR132185A1 true AR132185A1 (es) 2025-06-04

Family

ID=90717355

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240100690A AR132185A1 (es) 2023-03-24 2024-03-21 COMPUESTOS DE 1-H-PIRROLO[2,3-c]PIRIDINA

Country Status (14)

Country Link
US (2) US20240335431A1 (es)
KR (1) KR20250168403A (es)
CN (1) CN121443605A (es)
AR (1) AR132185A1 (es)
AU (1) AU2024254125A1 (es)
CL (1) CL2025002813A1 (es)
CO (1) CO2025014690A2 (es)
CR (1) CR20250445A (es)
DO (1) DOP2025000237A (es)
IL (1) IL323490A (es)
MX (1) MX2025011196A (es)
PE (1) PE20252679A1 (es)
TW (1) TW202440083A (es)
WO (1) WO2024201240A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019003091A (es) * 2016-09-16 2019-07-08 Vitae Pharmaceuticals Inc Inhibidores de la interaccion de menina-mll.
US10815241B2 (en) 2018-08-27 2020-10-27 Sumitomo Dainippon Pharma Co., Ltd. Optically active azabicyclo ring derivative
WO2021060453A1 (ja) * 2019-09-27 2021-04-01 大日本住友製薬株式会社 架橋型光学活性２級アミン誘導体
CR20230605A (es) * 2021-06-01 2024-05-24 Janssen Pharmaceutica Nv Derivados de fenil-1h-pirrolo[2,3-c]piridina sustituidos

Also Published As

Publication number Publication date
MX2025011196A (es) 2025-10-01
CN121443605A (zh) 2026-01-30
KR20250168403A (ko) 2025-12-02
CR20250445A (es) 2025-11-27
IL323490A (en) 2025-11-01
TW202440083A (zh) 2024-10-16
AU2024254125A1 (en) 2025-11-13
CO2025014690A2 (es) 2025-10-30
US20240335431A1 (en) 2024-10-10
WO2024201240A1 (en) 2024-10-03
US20250360112A1 (en) 2025-11-27
DOP2025000237A (es) 2025-11-16
CL2025002813A1 (es) 2025-10-17
PE20252679A1 (es) 2025-11-24

Similar Documents

Publication Publication Date Title
MX2021014096A (es) Compuestos heterociclicos, metodos de preparacion y usos de estos.
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
MX2024010399A (es) Derivados de 6-oxodecahidropirrolo[1,2-a][1,5]diazocina y 6-oxodecahidro-4h-pirrolo[2,1-d][1,5]tiazocina como moduladores de stat3 y stat6 para el tratamiento de cáncer y condiciones inflamatorias
CL2020002698A1 (es) Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos
UY33961A (es) Compuestos de bis(fuoroalquil)-1,4-benziodiazepinona
PA8537501A1 (es) Naftostirilos
AR125672A1 (es) Derivados de fósforo como nuevos inhibidores de sos1
BR112021022536A2 (pt) Derivado de fenilpropenilpiridina substituída e método de preparação do mesmo e uso médico do mesmo
AR054799A1 (es) Derivados de oxindol
BR112022022669A2 (pt) Inibidores de nek7 quinase
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
UY28514A1 (es) Nuevos compuestos
AR131380A1 (es) Purinas 2,6,9-trisustituidas
UY27870A1 (es) Nuevos derivados de quinuclidina-amida
BR112018007772A2 (pt) compostos de imidazo[4,5-c]quinolin-2-ona e seu uso no tratamento do câncer
ECSP077323A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
BR112023019435A2 (pt) Inibidores de nek7
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
MX2024007312A (es) Inhibidor doble de pde3/4 heterociclico condensado triciclico y uso de este.
CR20230481A (es) Compuestos de piridina y piridazina metil-sustituidos, derivados de los mismos y métodos de su uso
MX2022000598A (es) Preparacion de compuestos antibacterianos.
BR112022022452A2 (pt) Inibidores de il4i1 e métodos de uso
CO2024010542A2 (es) Inhibidores de apol1 y métodos de uso
CO2022019131A2 (es) Inhibidores de la quinasa nek7
UY27232A1 (es) Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos